Navigation Links
Discovery Labs Reports Second Quarter 2012 Financial Results
Date:8/2/2012

WARRINGTON, Pa., Aug. 2, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today reports financial results for the second quarter ended June 30, 2012 and provides a business update.  The Company will host a conference call this morning at 10:00 AM ET.  Conference call details are below.

Key operating updates and financial information include:

  • The Company has made significant progress in building its own specialty commercial and medical affairs organizations to specialize in neonatal respiratory critical care.  These organizations will implement the commercialization of the Company's products and provide medical and scientific information to the neonatal medical community regarding the Company's proprietary KL4 surfactant and aerosol drug delivery technologies.
  • The Company remains on track to launch SURFAXIN® in the U.S. in the fourth quarter of 2012.  SURFAXIN is the first synthetic, peptide-containing surfactant approved for use in neonatal medicine and provides healthcare practitioners with an alternative to the animal-derived surfactants that today are the standard of care to manage respiratory distress syndrome (RDS) in premature infants.  The Company also remains on track to launch the neonatal size AFECTAIR® device in the fourth quarter of 2012. 
  • To advance the AEROSURF® program, the Company entered into a Research and Development Services Agreement ("Agreement") with Battelle Memorial Institute ("Battelle"), the world's largest nonprofit research and development organization with expertise in developing and integrating aerosol devices using innovative and advanced technologies.  Battelle will provide technical support and expertise to op
    '/>"/>

  • SOURCE Discovery Laboratories, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    2. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
    3. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery
    4. Discovery of a dark state could mean a brighter future for solar energy
    5. Thomson Reuters Research Forecasts the Onset of the Targeted Drug Discovery Era
    6. AnaptysBio Announces New Strategic Antibody Discovery
    7. Discovery opens door to low-cost negative refraction, new products and industries
    8. Thomson Reuters Cortellis Drives Drug Discovery and Development With Powerful New Web Services
    9. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
    10. AlphaBio Centrix, LLC Announces a New Discovery for Programming Energetic Patches
    11. Mars, Incorporated Answers Question: How Does Feeding People and Pets Nurture Science and Discovery? At TEDMED 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
    (Date:12/24/2014)... AUSTIN, Texas , Dec. 24, 2014  Vermillion, ... focused on gynecologic disease, announced today that the ... investors including Oracle Investment Management, Jack W. ... directors. Total proceeds were $10.5 million, before offering ...
    (Date:12/24/2014)... MA (PRWEB) December 23, 2014 Earlier this ... L. Sherley, director of the Adult Stem Cell Technology Center, ... and under appreciated unique property of adult tissue stem cells. ... in the Past, Important for the Future,” embodied the essence ...
    (Date:12/24/2014)... Dallas, Texas (PRWEB) December 23, 2014 ... mercaptan such as its definition, classification, application and ... manufacturing process, and product cost structure. Production is ... also covers upstream raw materials, equipment, downstream client ...
    Breaking Biology Technology:Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
    ... 4, 2011 Advanced Life Sciences Holdings, Inc. ... biopharmaceutical company engaged in the discovery, development and commercialization ... oncology and respiratory diseases, today announced that it will ... held January 10-12th in San Francisco. ...
    ... 2011 Neogen Corporation (Nasdaq: NEOG ) announced ... FY 2011, which ended Nov. 30, increased 33% from the ... to $6,110,000, or $0.26 per share, compared to the prior ... $43,931,000, compared to the prior year,s $35,251,000. Year-to-date revenues for ...
    ... Inc. announced today that it has received clearance from ... to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ... solid tumors. (Logo: http://photos.prnewswire.com/prnh/20101101/NY92716LOGO ) ... the activity of semaphorin 4D (SEMA4D).  It is the ...
    Cached Biology Technology:Advanced Life Sciences to Present at the Biotech Showcase™ 2011 Conference 2Neogen Reports 33% Increase in Net Income 2Neogen Reports 33% Increase in Net Income 3Neogen Reports 33% Increase in Net Income 4Neogen Reports 33% Increase in Net Income 5Vaccinex, Inc. Initiates Clinical Trial of Novel Therapeutic Antibody in Cancer Patients With Advanced Solid Tumors 2
    (Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) has announced ... Home Button Synaptics Fingerprint Sensor Technology Analysis" report ... Based on a totally different sensing ... first time a fingerprint sensor in its product. ...
    (Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" report ... One major trend upcoming in this ... biomedical applications. Chemical sensors help in recording of patient ...
    (Date:12/11/2014)... Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... addition of the "Biometrics Market in India 2015-2019" ... major trend emerging in this market is the adoption ... than one characteristic of an individual for verification and ...
    Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
    ... is a newly discovered life history among the 28,300 species ... from arid southwestern Madagascar spends up to three-quarters of its ... is a mere 4 to 5 months. No other known ... a short life span. The new research is reported in ...
    ... Mary Estes of Baylor College of Medicine and her ... toxic protein that affects the intestines, causing diarrhea. ... receptor on intestinal cells through which the enterotoxin interacts ... the receptor might not be straightforward," said the professor ...
    ... factors associated with Crohn,s disease have been discovered, ... about the disease. An international consortium of Crohn,s ... Canadian researchers Dr. John D. Rioux from ... Drs. Mark Silverberg and Hillary Steinhart from Mount ...
    Cached Biology News:Unheard of life history for a vertebrate 2Integrins as receptors give insight into rotavirus and diarrhea 2Montreal Heart Institute and Mount Sinai Hospital researchers contribute to Crohn's disease study 2
    Incomplete Adjuvant...
    The ELISA Kit for Hepatitis B Surface Antigen (HBsAg) is an in vitro enzyme immunoassay for the detection of HBsAg in human serum or plasma....
    HiTrap Streptavidin HP, 5 x 1 ml. Category: Chromatography Systems & Accessories, Systems....
    IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
    Biology Products: